WallStreetZenWallStreetZen

NYSE: BAX
Baxter International Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

BAX past earnings growth

How has BAX's earnings growth performed historically?
Company
N/A
Industry
22.79%
Market
107.64%
BAX's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
BAX's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance

BAX past revenue growth

How has BAX's revenue growth performed historically?
Company
2.12%
Industry
7.99%
Market
17.61%
BAX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
BAX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
BAX's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

BAX earnings and revenue history

Current Revenue
$14.8B
Current Earnings
$2.7B
Current Profit Margin
17.9%
BAX's has not demonstrated consistent... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

BAX Return on Equity

Current Company
38%
Current Industry
11.1%
Current Market
188%
BAX's Return on Equity (38%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when BAX announces earnings.

BAX Return on Assets

Current Company
9.2%
Current Industry
7.2%
BAX is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

BAX Return on Capital Employed

Current Company
14.07%
Current Industry
9.7%
BAX has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

BAX vs Medical Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
BAX$14.81B$4.33B$2.66B+5.94%+12.60%
COO$3.67B$934.70M$290.80M+7.36%-4.63%
HOLX$3.97B$1.06B$515.10M+4.03%+60.43%
RMD$4.50B$1.37B$890.39M+12.91%+13.98%
WST$2.95B$862.00M$593.40M+11.43%+23.30%
View Top Medical Stocks

BAX earnings dates

Next earnings date
May 2, 2024

Baxter International Earnings & Revenue FAQ

What were BAX's earnings last quarter?

On Invalid Date, Baxter International (NYSE: BAX) reported Q4 2023 earnings per share (EPS) of $0.49, up 32.43% year over year. Total Baxter International earnings for the quarter were $245.00 million. In the same quarter last year, Baxter International's earnings per share (EPS) was $0.37.

If you're new to stock investing, here's how to buy Baxter International stock.

What was BAX's earnings growth in the past year?

As of Q2 2024, Baxter International's earnings has grown year over year. Baxter International's earnings in the past year totalled $2.66 billion.

What is BAX's earnings date?

Baxter International's earnings date is Invalid Date. Add BAX to your watchlist to be reminded of BAX's next earnings announcement.

What was BAX's revenue last quarter?

On Invalid Date, Baxter International (NYSE: BAX) reported Q4 2023 revenue of $3.89 billion up 3.74% year over year. In the same quarter last year, Baxter International's revenue was $3.75 billion.

What was BAX's revenue growth in the past year?

As of Q2 2024, Baxter International's revenue has grown 2.12% year over year. This is 5.88 percentage points lower than the US Medical Instruments & Supplies industry revenue growth rate of 7.99%. Baxter International's revenue in the past year totalled $14.81 billion.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.